PharmaCyte Biotech
Open
$0.74
Prev. Close
$0.74
High
$0.74
Low
$0.73
Market Snapshot
$7.6M
-0.8
0.53
2
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. The company is headquartered in Las Vegas, Nevada and currently employs 2 full-time employees. The company went IPO on 2003-09-11. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC) will be developed. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used as a means to produce various biologically active molecules. The technology is intended to result in the formation of pinhead-sized cellulose-based porous capsules in which genetically modified live human cells can be encapsulated and maintained. In a laboratory setting, this proprietary live cell encapsulation technology has been shown to create a micro-environment in which encapsulated cells survive and flourish.
emptyResult
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. The company is headquartered in Las Vegas, Nevada and currently employs 2 full-time employees. The company went IPO on 2003-09-11. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC) will be developed. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used as a means to produce various biologically active molecules. The technology is intended to result in the formation of pinhead-sized cellulose-based porous capsules in which genetically modified live human cells can be encapsulated and maintained. In a laboratory setting, this proprietary live cell encapsulation technology has been shown to create a micro-environment in which encapsulated cells survive and flourish.
Recently from Cashu
Please provide the content you would like me to summarize, and I'll create the title for you.
Certainly! Please provide the content you'd like me to summarize, and I'll create an article based on your instructions.
Please provide the content you would like me to summarize.
Sure! Please provide the text you would like me to summarize.
It seems there was an oversight! Please provide the content you'd like summarized, and I'll create a title for you.
Certainly! Please provide the content you would like me to summarize.
PharmaCyte Biotech Advances Innovative Cell Therapy for Cancer and Diabetes Management
PharmaCyte Biotech Advances Cell Therapy Initiatives PharmaCyte Biotech, a company specializing in cell-based therapies for cancer and diabetes, is making significant strides in its clinical developme…